Abstract
The availability and use of pre-sterilized disposables has greatly changed the methods used in biopharmaceuticals development and production, particularly from mammalian cell culture. Nowadays, almost all process steps from cell expansion, fermentation, cell removal, and purification to formulation and storage of drug substances can be carried out in disposables, although there are still limitations with single-use technologies, particularly in the areas of pretesting and quality control of disposables, bag and connections standardization and qualification, extractables and leachables (E/L) validation, and dependency on individual vendors. The current status of single-use technologies is summarized for all process unit operations using a standard mAb process as an example. In addition, current pros and cons of using disposables are addressed in a comparative way, including quality control and E/L validation.
The continuing progress in developing single-use technologies has an important impact on manufacturing facilities, resulting in much faster, less expensive and simpler plant design, start-up, and operation, because cell culture process steps are no longer performed in hard-piped unit operations. This leads to simpler operations in a lab-like environment. Overall it enriches the current landscape of available facilities from standard hard-piped to hard-piped/disposables hybrid to completely single-use-based production plants using the current segregation and containment concept. At the top, disposables in combination with completely and functionally closed systems facilitate a new, revolutionary design of ballroom facilities without or with much less segregation, which enables us to perform good manufacturing practice manufacturing of different products simultaneously in unclassified but controlled areas.
Finally, single-use processing in lab-like shell facilities is a big enabler of transferring and establishing production in emergent countries, and this is described in more detail in 7.
References
Mahajan E, Dent K, Chan E, Hudson T (2014) UNICAN: dual capability in single use bioreactors, Cell Culture Engineering XIV, April 2014, Quebec, Canada
Gikanga B et al. (2015) Mixing monoclonal antibody formulations using bottom-mounted mixers: impact of mechanism and design on drug product quality. PDA J Pharma Sci Technol 69:284–296
Goldstein A (2015) Pharmaceutical engineering, vol 35. ISPE, Bethesda
Samavedam R, Goldstein A, Schieche D (2006) Implementation of disposables: validation and other considerations. Am Pharm Rev 9(5):46–51
Goldstein A, Pohlscheidt M (2012) Disposable freeze systems in the pharmaceutical industry. Am Pharm Rev 15, 53–58
Boedeker B (2012) Improving biologic manufacturing operations and plant design through single-use technologies applications. Pharm Outsourcing 13:12–17
Boedeker B (2013) Assessing possibilities and preventing the risk of using disposables. BioPharma Asia Vol 2(2) March/April 2013, 38–45
Leveen L (2009) Single use technology and its carbon and water footprints, part 2. Am Pharm Rev 13:50–56
Ding W et al. (2014) Standardized extractables testing protocol for single use systems in biomanufacturing. Pharm Eng 34(6), 1–11
Boedeker B (2014) Facility of the future: effect of disposables and continuous processing on plant design. BioPharma Asia Vol 4(3) May/June 2014, 24–27
Chalk S et al. (2011) Challenging the cleanroom paradigm for biopharmaceutical manufacturing of bulk drug substance. BioPharm Int Aug 2011:1–13
Mahajan E (2011) Microline: a fully disposable manufacturing facility. In: ISPE Annual Conference, Nov 2011
Hudson T (2014) Evaluating where single-use technology provides the most value for a company with well established manufacturing infrastructure. 247th ACS National Meeting and Exposition, March 16–20, 2014, Dallas, Texas Chemistry and Materials for Energy
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Boedeker, B., Goldstein, A., Mahajan, E. (2017). Fully Disposable Manufacturing Concepts for Clinical and Commercial Manufacturing and Ballroom Concepts. In: Kiss, B., Gottschalk, U., Pohlscheidt, M. (eds) New Bioprocessing Strategies: Development and Manufacturing of Recombinant Antibodies and Proteins. Advances in Biochemical Engineering/Biotechnology, vol 165. Springer, Cham. https://doi.org/10.1007/10_2017_19
Download citation
DOI: https://doi.org/10.1007/10_2017_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-97108-7
Online ISBN: 978-3-319-97110-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)